Skip to main content

Comprehensive HPV Screening Important in Male Urology, Fertility Clinics

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 23, 2024.

By Elana Gotkine HealthDay Reporter

FRIDAY, Aug. 23, 2024 -- Comprehensive human papillomavirus (HPV) screening, including genotyping, is important in urology and fertility clinics, according to a study published online Aug. 23 in Frontiers in Cellular and Infection Microbiology.

Carolina Olivera, Ph.D., from the FOCIS Center of Excellence Centro de Inmunología Clínica de Córdoba in Argentina, and colleagues examined the influence of high-risk HPV (HR-HPV) and low-risk HPV (LR-HPV) urogenital infection on male fertility in a study involving 205 male patients attending a urology clinic. Semen samples were analyzed for HPV; the quality of semen was assessed following World Health Organization guidelines.

The researchers detected HPV in 19 percent of semen samples. HR-HPV infections were more prevalent; the most frequent genotype was HPV-16. No significant alterations in routine sperm quality parameters were seen in association with HR-HPV or LR-HPV. However, significantly higher levels of sperm necrosis were seen in HR-HPV-positive individuals compared with LR-HPV-positive or control individuals, and they had increased proportions of reactive oxygen species-positive spermatozoa. Neither patients infected with HR-HPV nor LR-HPV had significant semen inflammation detected; compared with controls, unexpectedly reduced serum leukocytes and inflammatory cytokines (interleukin 6 and interleukin 1β) were seen in HR-HPV-positive patients.

"A more thorough evaluation, including genotyping, is essential for males seeking care at urology and fertility clinics, since the specific HPV genotype may influence the course of the infection and its consequences on reproductive health," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted August 2024

Read this next

Mailed Self-Collection Kits Increase Rates of Cervical Cancer Screening

WEDNESDAY, June 11, 2025 -- Mailed self-collection (SC) kits may increase participation in cervical cancer screening, according to a study published online June 6 in JAMA...

Parents Appear Receptive to Children Receiving HPV Vaccine at 9 or 10 Years of Age

MONDAY, June 2, 2025 -- Clinicians consider administration of human papillomavirus (HPV) vaccine as feasible at age 9 to 10 years, and parents appear to be receptive to discussing...

HPV Genome Sequencing Superior in Detecting Head & Neck Cancer

THURSDAY, May 29, 2025 -- Human papillomavirus (HPV) whole-genome sequencing (WGS)-based circulating tumor DNA (ctDNA) detection has the highest sensitivity, specificity, and...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.